Artiva to wind down after two patient deaths in autoimmune cell therapy trials
Cell therapy biotech Artiva Biotherapeutics abruptly announced Tuesday morning that it is effectively shutting down and laying off almost all of its staff after two patients died in its clinical trials. Researchers had been testing ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.